Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg T Motz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Immunity|July 30, 2013
Deciphering and reversing tumor immune suppressionGreg T Motz, George Coukos
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary diseaseBrian W Wortham, Bryan L Eppert, Greg T Motz, et al.
Plos One|May 4, 2022
BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activityTaylor L Hickman, Eugene Choi, Kathleen R Whiteman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Immunity|July 30, 2013
Deciphering and reversing tumor immune suppressionGreg T Motz, George Coukos
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary diseaseBrian W Wortham, Bryan L Eppert, Greg T Motz, et al.
Plos One|May 4, 2022
BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activityTaylor L Hickman, Eugene Choi, Kathleen R Whiteman, et al.
Pageof 1